| CRISPR-Cas9 gene editing for sickle cell disease and β-thalassemia H Frangoul, D Altshuler, MD Cappellini, YS Chen, J Domm, BK Eustace, ... New England Journal of Medicine 384 (3), 252-260, 2021 | 1243 | 2021 |
| Sickle cell disease RE Ware, M de Montalembert, L Tshilolo, MR Abboud The Lancet 390 (10091), 311-323, 2017 | 948 | 2017 |
| Gene therapy in a patient with sickle cell disease JA Ribeil, S Hacein-Bey-Abina, E Payen, A Magnani, M Semeraro, ... New England Journal of Medicine 376 (9), 848-855, 2017 | 736 | 2017 |
| Gene therapy in patients with transfusion-dependent β-thalassemia AA Thompson, MC Walters, J Kwiatkowski, JEJ Rasko, JA Ribeil, ... New England Journal of Medicine 378 (16), 1479-1493, 2018 | 692 | 2018 |
| Anemia in children: prevalence, causes, diagnostic work-up, and long-term consequences S Allali, V Brousse, AS Sacri, M Chalumeau, M de Montalembert Expert review of hematology 10 (11), 1023-1028, 2017 | 191 | 2017 |
| Recommendations regarding splenectomy in hereditary hemolytic anemias A Iolascon, I Andolfo, W Barcellini, F Corcione, L Garçon, L De Franceschi, ... haematologica 102 (8), 1304, 2017 | 191 | 2017 |
| Hydroxyurea can eliminate transfusion requirements in children with severe β-thalassemia M Bradai, MT Abad, S Pissard, F Lamraoui, L Skopinski, ... Blood 102 (4), 1529-1530, 2003 | 179 | 2003 |
| A biomimetic microfluidic chip to study the circulation and mechanical retention of red blood cells in the spleen J Picot, PA Ndour, SD Lefevre, W El Nemer, H Tawfik, J Galimand, ... American journal of hematology 90 (4), 339-345, 2015 | 175 | 2015 |
| Two new human DMT1 gene mutations in a patient with microcytic anemia, low ferritinemia, and liver iron overload C Beaumont, J Delaunay, G Hetet, B Grandchamp, M de Montalembert, ... Blood 107 (10), 4168-4170, 2006 | 150 | 2006 |
| Acute clinical events in 299 homozygous sickle cell patients living in France MG Neonato, M Guilloud‐Bataille, P Beauvais, P Bégué, M Belloy, ... European journal of haematology 65 (3), 155-164, 2000 | 149 | 2000 |
| Sickle cell disease as a paradigm of immigration hematology: new challenges for hematologists in Europe I Roberts, M de Montalembert Haematologica 92 (7), 865-871, 2007 | 147 | 2007 |
| Complications and treatment of patients with β-thalassemia in France: results of the National Registry I Thuret, C Pondarré, A Loundou, D Steschenko, R Girot, D Bachir, ... haematologica 95 (5), 724, 2010 | 134 | 2010 |
| Long-term hydroxyurea treatment in children with sickle cell disease: tolerance and clinical outcomes M de Montalembert, V Brousse, C Elie, F Bernaudin, J Shi, P Landais, ... haematologica 91 (1), 125-128, 2006 | 133 | 2006 |
| Acute splenic sequestration crisis in sickle cell disease: cohort study of 190 paediatric patients V Brousse, C Elie, M Benkerrou, MH Odièvre, E Lesprit, F Bernaudin, ... British journal of haematology 156 (5), 643-648, 2012 | 131 | 2012 |
| Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease M De Montalembert, M Belloy, F Bernaudin, F Gouraud, R Capdeville, ... Journal of pediatric hematology/oncology 19 (4), 313-318, 1997 | 125 | 1997 |
| Prognosis of patients with sickle cell disease and COVID-19: a French experience JB Arlet, G de Luna, D Khimoud, MH Odièvre, M de Montalembert, ... The Lancet Haematology 7 (9), e632-e634, 2020 | 123 | 2020 |
| Delayed hemolytic transfusion reaction in children with sickle cell disease M De Montalembert, MD Dumont, C Heilbronner, V Brousse, O Charrara, ... haematologica 96 (6), 801, 2011 | 116 | 2011 |
| Clinical outcomes associated with sickle cell trait: a systematic review RP Naik, K Smith-Whitley, KL Hassell, NI Umeh, M De Montalembert, ... Annals of Internal Medicine 169 (9), 619-627, 2018 | 114 | 2018 |
| Newborn screening for sickle cell disease in Europe: recommendations from a Pan‐European Consensus Conference S Lobitz, P Telfer, E Cela, B Allaf, M Angastiniotis, C Backman Johansson, ... British journal of haematology 183 (4), 648-660, 2018 | 114 | 2018 |
| Fetal hemoglobin and F-cell responses to long-term hydroxyurea treatment in young sickle cell patients M Maier-Redelsperger, M de Montalembert, A Flahault, MG Neonato, ... Blood, The Journal of the American Society of Hematology 91 (12), 4472-4479, 1998 | 113 | 1998 |
